P. Dettmar

发表

[Using the Fick's shifting hypothesis to explain dyschromatopsia in a model computation for data processing of disordered colored vision in man].

P. Dettmar, 1972, Kybernetik.

Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer

P. Dettmar, J. Breul, F. May, 2001, BJU international.

Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value.

P. Dettmar, M. Schmitt, H. Zeilhofer, 2005, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Long-term prognostic impact of PAI-1 in primary breast cancer confirmed by six-year median follow-up

H. Höfler, N. Harbeck, P. Dettmar, 1997 .

Laser therapy of a dermal nevus in the esthetic zone of the nasal tip: A case report and comprehensive literature review

P. Dettmar, D. Nolte, Johannes Angermair, 2015, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

H. Höfler, N. Harbeck, P. Dettmar, 1999, British Journal of Cancer.

Prognostic impact of tumor biological factors on survival in node-negative breast cancer.

H. Höfler, N. Harbeck, P. Dettmar, 1998, Anticancer research.

Invasion F actors u PA/PAI-1 a nd H ER2 S tatus P rovide Independent a nd C omplementary I nformation o n P atient Outcome i n N ode-Negative B reast C ancer

M. Kiechle, N. Harbeck, P. Dettmar, 2003 .

Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.

H. Höfler, M. Kiechle, N. Harbeck, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.

N. Harbeck, P. Dettmar, K. Ulm, 1999, International journal of oncology.

Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.

H. Höfler, P. Dettmar, F. Jänicke, 1995, Cancer research.